SILENCE THERAP. SP.ADR/1 (XRP2) — Free Cash Flow Generation Index

Latest as of December 2021: 0.80x

SILENCE THERAP. SP.ADR/1 (XRP2) has a Free Cash Flow Generation Index of 0.80x as of December 2021. Free cash flow of €7.39 Million represents 1% of operating cash flow (€9.19 Million). Read SILENCE THERAP. SP.ADR/1 debt and liabilities for a breakdown of total debt and financial obligations.

FCF Generation Index

0.80x

Free Cash Flow / Operating CF

Free Cash Flow

€7.39 Million

EUR

Operating Cash Flow

€9.19 Million

EUR

Capital Expenditures

€1.80 Million

EUR

SILENCE THERAP. SP.ADR/1 Free Cash Flow Generation Index (2021–2021)

Historical FCF Generation Index trend for SILENCE THERAP. SP.ADR/1 across 1 annual periods. Explore XRP2 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for SILENCE THERAP. SP.ADR/1 (2021–2021)

Year-by-year Free Cash Flow Generation Index for SILENCE THERAP. SP.ADR/1. For the full company profile including market capitalisation, see SILENCE THERAP. SP.ADR/1 (XRP2) total market value.

Year	FCG Index	Free Cash Flow (EUR)	Operating CF	Capital Expenditures	YoY Change
2021	0.80x	€7.39 Million	€9.19 Million	€1.80 Million	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).